GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » Gross Profit

Vanta Bioscience (BOM:540729) Gross Profit : ₹59.06 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience Gross Profit?

Vanta Bioscience's gross profit for the six months ended in Sep. 2024 was ₹23.28 Mil. Vanta Bioscience's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ₹59.06 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Vanta Bioscience's gross profit for the six months ended in Sep. 2024 was ₹23.28 Mil. Vanta Bioscience's Revenue for the six months ended in Sep. 2024 was ₹10.31 Mil. Therefore, Vanta Bioscience's Gross Margin % for the quarter that ended in Sep. 2024 was 225.86%.

Vanta Bioscience had a gross margin of 225.86% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Vanta Bioscience was 129.01%. The lowest was 84.25%. And the median was 91.06%.


Vanta Bioscience Gross Profit Historical Data

The historical data trend for Vanta Bioscience's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience Gross Profit Chart

Vanta Bioscience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial 128.79 91.94 89.18 52.87 89.71

Vanta Bioscience Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.11 28.77 53.93 35.78 23.28

Competitive Comparison of Vanta Bioscience's Gross Profit

For the Diagnostics & Research subindustry, Vanta Bioscience's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vanta Bioscience's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vanta Bioscience's Gross Profit distribution charts can be found below:

* The bar in red indicates where Vanta Bioscience's Gross Profit falls into.


;
;

Vanta Bioscience Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Vanta Bioscience's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=97.229 - 7.519
=89.71

Vanta Bioscience's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=10.305 - -12.97
=23.28

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹59.06 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Vanta Bioscience's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=23.28 / 10.305
=225.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vanta Bioscience  (BOM:540729) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vanta Bioscience had a gross margin of 225.86% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Vanta Bioscience Gross Profit Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Vanta Bioscience Business Description

Traded in Other Exchanges
N/A
Address
No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003
Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines